Shenzhen, Guangdong Province, China, April 29, 2025 — MR FOG, a trailblazer in the vaping industry, is excited to announce the launch of its MR FOG NOVA Blue Razz Steezy Series, a groundbreaking collection of disposable… Read More »MR FOG Launches NOVA Blue Razz Steezy Series: Elevating Blue Raspberry Vaping
SILICON VALLEY, Calif., April 30, 2025 /PRNewswire/ — VOC.AI, a North America leader in AI-driven customer service solutions and intelligent insights, announced today the successful completion of a new multi-million-dollar funding round. The investment was led… Read More »VOC.AI Secures 15 Million Dollars Funding to Fuel Global Growth and Transform AI-Driven Customer Service Solutions
BeMine Marks Seven Years with “Birthday Bash” Campaign, Featuring Gamified Rewards, PAWA Token Airdrop, and Significant Discounts Victoria, Seychelles, April 29, 2025 (GLOBE NEWSWIRE) — Cloud mining provider BeMine.club is marking its 7th anniversary by… Read More »BeMine Celebrates 7 Years with Gamified Mining Rewards and Token Airdrops
Celebrating 7 years, Canada’s longest-running Web3 event brings the industry’s top speakers to the most immersive stage in Web3. TORONTO, April 29, 2025 (GLOBE NEWSWIRE) — Blockchain Futurist Conference, Canada’s largest and longest-running Web3 event,… Read More »Blockchain Futurist Conference Returns in Two Weeks with Founders of Cardano, Tezos, Tether, and Ethereum Headlining
CD ComputaBio announces today a groundbreaking computational platform that accelerates the design of Antibody-Drug Conjugates (ADCs) and significantly decreases the timelines and costs associated with developing these targeted therapeutics for cancer treatment. Shirley, New York,… Read More »CD ComputaBio Pioneers Next Generation of ADC Design with Groundbreaking Computational Solution
CD ComputaBio has launched its advanced Drug Molecule Optimization service, offering pharmaceutical researchers sophisticated computational approaches to accelerate therapeutic development while improving drug candidate profiles. Shirley, New York, United States, April 29, 2025 — CD… Read More »CD ComputaBio Enhances Pharmaceutical Research with Innovative Drug Molecule Optimization Service